More News of Interest

NeoTract Inc. Announces Presentations of Multiple Clinical Studies Featuring Five-Year Data from Pivotal Randomized Trial of UroLift®


Announced at the American Urological Association 2017 Meeting

NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today announced activities planned for the 112th American Urological Association Annual Meeting taking place May 12-16 at the Boston Convention and Exhibition Center in Boston, Mass.

The company’s events and activities will highlight the UroLift® System, a revolutionary minimally invasive approach to treating benign prostatic hyperplasia (BPH), also called enlarged prostate. These presentations include:

  • Friday, May 12, 7:00 am ET in Room 156, poster presentation by Dr. Karl-Dietrich Sievert: Minimally Invasive Prostatic Urethral Lift (PUL) Efficacious in a Large Percentage of TURP Candidates: A Multi-Center German Study After Two Years
  • Saturday, May 13, 7:00am-9am ET in Room 252: presentations of results from the Crossover Study (Prof. Henry Woo); the LOCAL Study (Dr. Steven Gange); and Commercial Use (Dr. Andrew Hirsh)
  • Saturday, May 13, at 1:00pm ET in Room 162: Five-year results from the pivotal L.I.F.T. randomized study presented by Dr. Claus Roehrborn as part of a podium session titled BPH: Surgical Therapy & New Technology IV
  • Sunday, May 14, 9:30-10:30am ET, in the Plenary Room: A presentation of Prime Time Surgical Techniques featuring the UroLift System, including a presentation and case demonstration of the UroLift System by Dr. Shahin Tabatabei

Latest Posts

Don't Miss